Another Russian athlete tests positive for Meldonium

Image
IANS Moscow
Last Updated : Mar 21 2016 | 4:42 PM IST

Russian track-and-field athlete Nadezhda Kotlyarova, a silver medallist of the 2013 European Athletics Indoor Championships in 4x400 metres relay race, has tested positive for the banned drug Meldonium, her coach Sergei Vorobyov has said.

The test was taken during the Russian indoors championships in February. As soon as the results of the test were announced, Kotlyarova had to leave the team currently on a training session in Adler, reports Tass ness agency.

"This medicine was prescribed to Nadezhda by doctors. She had been taking it for at least six months before stopping to use it," Vorobyov said on Sunday.

"No one has ever told us how long it takes to clear the organism from this medicine. As a matter of fact, the situation looks strange. We are waiting how the situation develops."

Kotlyarova was third in the 400 metres race at the Russian indoor championships held in Moscow from February 23 to 25.

Russian sports was hit last week by a new case in a chain of doping-related incidents after some of the country's athletes tested positive for banned substance Meldonium.

Meldonium was added to the World Anti-Doping Agency (WADA) list of banned substances on September 16, 2015, effective starting January 1, 2016. It was previously on WADA's list of drugs to be monitored.

WADA considers the drug to be a "metabolic modulator", similar to insulin. A December 2015 study in the journal Drug Testing and Analysis argued that Meldonium "demonstrates an increase in endurance performance of athletes, improved rehabilitation after exercise, protection against stress, and enhanced activations of central nervous system (CNS) functions."

According to latest reports, more than a hundred of athletes from across the world have tested positive for Meldonium.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 21 2016 | 4:24 PM IST

Next Story